| Literature DB >> 31285459 |
Chan Hyuk Park1, Yoon Suk Jung2, Nam Hee Kim3, Mi Yeon Lee4, Jung Ho Park5, Dong Il Park5, Chong Il Sohn5.
Abstract
Although it is known that ambient temperature can affect the diagnostic performance of the fecal immunochemical test (FIT), the impact of other weather parameters, including humidity, on the sensitivity of FIT remains to be further investigated. We aimed to evaluate the impact of ambient temperature and humidity on the performance of FIT for screening for advanced colorectal neoplasia (ACRN). We included asymptomatic individuals who had undergone both screening colonoscopy and FIT. The diagnostic performance of FIT, including its sensitivity, was analyzed according to the ambient temperature and humidity on the day that FIT was performed. Temperature and humidity were divided into five levels. Among 35,461 participants, 589 (1.7%) had ACRN. The positivity rate of FIT was lower at ≥24 °C (3.1%) than at <0 °C (3.9%), 0-8 °C (4.3%), and 8-16 °C (3.9%). It was also lower at 80-90% humidity (3.1%) than at < 60% humidity (3.9%). Multivariable analysis showed that high ambient temperature (≥24 °C) with high ambient humidity (≥80%) was associated with a low positivity rate of FIT (odds ratio [OR] 0.62, 95% confidence interval [CI] 0.44-0.86). Sensitivity tended to decrease at high ambient temperature (<24 °C vs. ≥24 °C; 20.8% vs. 14.6%, P = 0.110) and was significantly lower at high ambient humidity (<80% vs. ≥80%; 21.0% vs. 12.5%, P = 0.044). The multivariable analysis also showed that high ambient humidity was independently associated with low sensitivity of FIT (OR 0.54, 95% CI 0.28-0.96). In conclusion, high ambient humidity decreased the sensitivity, while high ambient temperature along with high ambient humidity decreased the positivity rate of FIT.Entities:
Mesh:
Year: 2019 PMID: 31285459 PMCID: PMC6614420 DOI: 10.1038/s41598-019-44490-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline patient characteristics, and timing of fecal immunochemical test.
| Variable | Total |
|---|---|
| N | 35461 |
| Age, year, mean ± SD (range) | 43.0 ± 8.6 |
| Male, n (%) | 25366 (71.5) |
| Family history of CRC, n (%) | 1302 (3.7) |
|
| |
| Never smoker | 17815 (50.2) |
| Former smoker | 8765 (24.7) |
| Current smoker | 8881 (25.0) |
| Obesity (BMI ≥ 25 kg/m2), n (%) | 12644 (35.7) |
| Hypertension, n (%) | 3098 (8.7) |
| Diabetes, n (%)a | 1922 (5.4) |
| Old cerebrovascular accident, n (%) | 158 (0.4) |
| Dyslipidemia, n (%) | 4427 (12.5) |
| Use of NSAIDs, n (%) | 1347 (3.8) |
| CRN, n (%) | 5936 (16.7) |
| ACRN, n (%)b | 589 (1.7) |
| Advanced adenoma | 567 (1.6) |
| Cancer | 27 (0.08) |
|
| |
| 1st quarter (January - March) | 5350 (15.1) |
| 2nd quarter (April - June) | 9505 (26.8) |
| 3rd quarter (July - September) | 11544 (32.6) |
| 4th quarter (October - December) | 9062 (25.6) |
|
| |
| HM-JACK test | 9864 (27.8) |
| OC-SENSOR DIANA test | 25597 (72.2) |
aThere are missing values in 10 individuals.
bFive participants with ACRN had both CRC and advanced adenoma.
CRC, colorectal cancer; BMI, body mass index; NSAID, nonsteroidal anti-inflammatory drug; CRN, colorectal neoplasia; ACRN, advanced colorectal neoplasia; FIT, fecal immunochemical test; SD, standard deviation; NA, not applicable.
Figure 1Monthly average outside temperatures (A) and humidity (B) from 2004 to 2015 in Seoul and Suwon in Korea, where the health examination centers in this study are located. Bar represents 95% confidence interval.
Figure 2Diagnostic performance of fecal immunochemical test for advanced colorectal neoplasia. Left and right panels indicate the sensitivity and specificity, respectively. Q1, Q2, Q3, and Q4 indicate the first, second, third, and fourth quarters, respectively. Bar represents 95% confidence interval. *P < 0.05, **P < 0.01.
Figure 3Diagnostic performance of fecal immunochemical test for advanced colorectal neoplasia according to different ambient temperatures and humidity. (A) positivity rate, (B) sensitivity, and (C) specificity of FIT. Bar represents 95% confidence interval. *P < 0.05, **P < 0.01, FIT, fecal immunochemical test.
Logistic regression models for diagnostic performance of fecal immunochemical test for advanced colorectal neoplasia.
| Variable | Positivity rate | Sensitivity | Specificity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | Crude OR (95% CI) | Adjusted OR (95% CI) | % | Crude OR (95% CI) | Adjusted OR (95% CI) | % | Crude OR (95% CI) | Adjusted OR (95% CI) | |||||||
| Age, /year | NA | 1.02 (1.01–1.03) | <0.001 | 1.02 (1.01–1.03) | <0.001 | NA | 1.01 (0.99–1.03) | 0.494 | 1.01 (0.98–1.03) | 0.642 | NA | 0.98 (0.98–0.99) | <0.001 | 0.99 (0.98–0.99) | <0.001 |
|
| |||||||||||||||
| Male | 3.5 | 0.93 (0.82–1.05) | 0.245 | 0.95 (0.82–1.11) | 0.538 | 19.7 | 1.12 (0.69–1.90) | 0.654 | 1.13 (0.59–2.16) | 0.709 | 96.8 | 1.12 (0.99–1.27) | 0.080 | 1.08 (0.92–1.26) | 0.337 |
| Female | 3.8 | 1 | 1 | 18.0 | 1 | 1 | 96.4 | 1 | 1 | ||||||
|
| |||||||||||||||
| Absent | 3.6 | 1 | 1 | 19.1 | 1 | 1 | 96.7 | 1 | 1 | ||||||
| Present | 3.9 | 1.09 (0.81–1.43) | 0.560 | 1.08 (0.80–1.42) | 0.602 | 24.0 | 1.33 (0.48–3.24) | 0.549 | 1.26 (0.45–3.08) | 0.635 | 96.5 | 0.95 (0.71–1.30) | 0.733 | 0.96 (0.72–1.32) | 0.784 |
|
| |||||||||||||||
| Never smoker | 3.6 | 1 | 1 | 18.3 | 1 | 1 | 96.6 | 1 | 1 | ||||||
| Former smoker | 3.5 | 0.98 (0.85–1.13) | 0.799 | 1.00 (0.86–1.18) | 0.954 | 19.9 | 1.11(0.66–1.84) | 0.695 | 1.07 (0.59–1.95) | 0.827 | 96.8 | 1.06 (0.92–1.23) | 0.422 | 1.02 (0.86–1.20) | 0.839 |
| Current smoker | 3.8 | 1.06 (0.92–1.21) | 0.420 | 1.14(0.97–1.33) | 0.111 | 20.1 | 1.23 (0.69–1.83) | 0.639 | 1.07 (0.59–1.95) | 0.834 | 96.6 | 1.00 (0.87–1.15) | 0.967 | 0.92 (0.78–1.08) | 0.322 |
|
| |||||||||||||||
| BMI < 25 kg/m2 | 3.7 | 1 | 1 | 20.3 | 1 | 1 | 96.6 | 1 | 1 | ||||||
| BMI ≥ 25 kg/m2 | 3.5 | 0.95 (0.85–1.07) | 0.412 | 0.94 (0.84–1.06) | 0.348 | 18.2 | 0.87 (0.57–1.32) | 0.516 | 0.85 (0.56–1.29) | 0.453 | 96.8 | 1.08 (0.95–1.22) | 0.229 | 1.07 (0.95–1.22) | 0.267 |
|
| |||||||||||||||
| <24 °C | 3.8 | 1 | 1 | 20.8 | 1 | 96.5 | 1 | 1 | |||||||
| ≥24 °C | 3.1 | 0.80 (0.70–0.92) | 0.002 | 0.96 (0.82–1.11) | 0.563 | 14.6 | 0.70 (0.39–1.22) | 0.110 | 97.1 | 1.17 (1.00–1.38) | 0.006 | 1.02 (0.87–1.20) | 0.855 | ||
|
| |||||||||||||||
| <80% | 3.8 | 1 | 1 | 21.0 | 1 | 1 | 96.5 | 1 | 1 | ||||||
| ≥80% | 3.1 | 0.81 (0.70–0.94) | 0.006 | 1.00 (0.84–1.18) | 0.975 | 12.5 | 0.54 (0.28–0.95) | 0.044 | 0.54 (0.28–0.96) | 0.047 | 97.1 | 1.19 (1.02–1.39) | 0.025 | 0.95 (0.80–1.14) | 0.569 |
|
| |||||||||||||||
| ≥24 °C and ≥80% | 0.62(0.44–0.86) | 0.005 | 1.80 (1.28–2.58) | <0.001 | |||||||||||
ACRN, advanced colorectal neoplasia; FIT, fecal immunochemical test; CRC, colorectal cancer; BMI, body mass index; OR, odds ratio; CI, confidence interval; NA, not applicable.
Figure 4Changes in sensitivity and specificity of fecal immunochemical test for advanced colorectal neoplasia according to different cut-off values in high-humidity (≥80%) environments. Bar represents 95% confidence interval. Asterisk represents P-value of comparison between the reduced cut-off value and the original one (20 μg hemoglobin/g feces). *P < 0.05, **P < 0.01, FIT, fecal immunochemical test.